Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2015

View Archived Issues

Ferring acquires assets of orthopedic biomaterial developer BioSET

Propanc starts animal studies of proteolytic proenzymes for cancer

RepliCel Life Sciences submits clinical trial application for RCS-01

ZP-GA-1 shows similar PK characteristics to native glucagon

Marathon sells non-strategic products to focus on treatments for rare diseases

Merck Serono and Sysmex Inostics announce opening of liquid biopsy RAS biomarker testing center

Cyclenium Pharma and Fundacion Medina form drug discovery agreement

Xeris Pharmaceuticals presents comparative PK/PD study of G-Pump and GlucaGen

Plasma kallikrein inhibitors disclosed in Kalvista Pharmaceuticals patent

U. S. researchers develop recombinant N. meningitidis factor H binding proteins

Isis reports chemically modified ssASOs targeting ataxin-3

Galapagos patents CFTR modulators

Takeda patent reveals prokineticin PKR1 receptor antagonists

New orexin receptor antagonists disclosed by Merck & Co.

Saroglitazar reverses biochemical manifestations of metabolic syndrome

Nobelpharma launches Zanosar i.v. infusion in Japan

Axitinib shows activity against mutant BCR-ABL1 leukemia

Eisai's phase III trial of eribulin in soft tissue sarcoma meets primary endpoint

AstraZeneca and Orca Pharmaceuticals partner to discover ROR gamma inhibitors

Isis Pharmaceuticals announces phase I results for prekallikrein inhibitor for HAE

Phase I results indicate ALKS-7106 does not warrant further development

Neurotrope releases topline results from phase IIa trial of bryostatin 1 for Alzheimer's disease

First patient treated in trial of Renevia in HIV-associated lipoatrophy

Eisai reports results from phase II trial of lenvatinib in NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...